Ep 77: Guest Merrick Ross
Melanoma Matters29 Joulu 2025

Ep 77: Guest Merrick Ross

Summary


In this episode of Melanoma Matters, hosts James Larkin and Sapna Patel engage with Merrick Ross, a seasoned surgical oncologist, discussing his background, the evolution of surgical practice with regards to melanoma treatment, and the importance of multidisciplinary collaboration. They explore innovations in neoadjuvant therapy, the critical role of pathology in treatment decisions, and the future directions of surgical approaches in metastatic melanoma. They discuss the need for continuous adaptation and collaboration in the ever-evolving landscape of melanoma treatment.


Keywords


melanoma, surgical oncology, neoadjuvant therapy, multidisciplinary care, pathology, metastatic melanoma, melanoma treatment, melanoma surgery, immunotherapy, clinical trials


Takeaways


Merrick Ross shares his journey from Chicago to surgical oncology.

Surgery for melanoma has evolved from a primary modality to a multimodal approach.

The importance of collaboration between surgical oncologists and medical oncologists is emphasized.

Neoadjuvant therapy is seen as a promising area for future research and treatment.

Ultrasound imaging is more effective than cross-sectional imaging for assessing nodal basins.

The role of pathology is crucial in understanding treatment responses and guiding future therapy.

Surgical decisions should be tailored based on individual patient responses and disease characteristics.

The need for less aggressive surgical interventions is highlighted as treatment evolves.

Merrick emphasizes the importance of understanding tumor biology in surgical decision-making.

The conversation underscores the collaborative nature of modern melanoma treatment.


Sound Bites


"We need to loop in the pathologist."

"Surgery has evolved over time."

"The decision to be aggressive or not is complex."


Chapters


00:00 Merrick's upbringing

06:30 Evolution of Surgical Oncology for Melanoma

12:44 The Role of Sentinel Node Biopsy

18:35 Merrick waxes sentimental about neoadjuvant therapy

24:47 Collaboration Collaboration Collaboration

26:46 The Role of Pathology in Treatment Decisions

36:41 Surgical Considerations in Immunotherapy

39:44 A lovely closing anecdote about Merrick

Jaksot(84)

Ep 81: IGNYTE trial (RP1 + nivo)

Ep 81: IGNYTE trial (RP1 + nivo)

SummaryThe conversation covers the published data from the IGNYTE study - RP1 + nivolumab: response rate and safety profile, RNA-seq analysis, and toxicity. The key takeaways include insights into cli...

13 Helmi 32min

Ep 80: 2025 Holiday Special

Ep 80: 2025 Holiday Special

SummaryHappy Holidays and Festive Season Everyone! In this episode of Melanoma Matters, hosts Sapna Patel and James reflect on their "cultural" experiences over the past year, discussing movies, music...

30 Joulu 202535min

Ep 79: coBRIM, COMBI-d 5-year follow-up

Ep 79: coBRIM, COMBI-d 5-year follow-up

SummaryIn this episode of Melanoma Matters, James awaits an invitation to a film premiere (The Penguin Lessons) and we all await a picture of him in his tuxedo! Sapna and James go on to discuss the 5-...

29 Joulu 202536min

Ep 78 TRAILER: MEK inhibitor trials

Ep 78 TRAILER: MEK inhibitor trials

Enjoy this short trailer on MEK inhibitor monotherapy trials in melanoma

29 Joulu 20251min

Ep 78: MEK inhibitor trials (METRIC, NEMO, pimasertib)

Ep 78: MEK inhibitor trials (METRIC, NEMO, pimasertib)

SummarySo many shoutouts in this episode of Melanoma Matters! Sapna and James engage in a lively discussion about MEK inhibitors as monotherapy treatment. They explore the METRIC, NEMO, and pimasertib...

29 Joulu 202537min

Ep 76: KEYNOTE 054 7-year follow-up

Ep 76: KEYNOTE 054 7-year follow-up

SummaryIn this Episode, hosts James & Sapna go into the 7-year follow-up from the randomized phase 3 adjuvant trial of pembrolizumab versus placebo for stage III melanoma, KEYNOTE-054There's a bit too...

28 Joulu 202528min

Ep 75: Immune-mediated Myocarditis

Ep 75: Immune-mediated Myocarditis

SummaryIn this (longest to-date) episode, James and Sapna delve into the not-so-rare occurence of immune-mediated myocarditis, particularly in the context of immune checkpoint inhibitors. The hosts di...

28 Joulu 20251h 4min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
rss-hanna-tikander
rss-pitaisko-erota
rss-narsisti
voi-hyvin-meditaatiot-2
tiedenaiset-podcast
psykopodiaa-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
puhu-muru
rss-kuumilla-aalloilla
selviytyjat-tarinoita-elamasta
katilon-kahvitunti
fitnessvastaanotto
rss-pt-paahtio
rss-vapaudu-voimaasi
rss-rentoudu-podcast-rentoutumiseen-hanna-viljanmaa
meditaatiot-suomeksi
paritellen
rss-seuraava-potilas
rss-uplevel-by-sonja-hannus